C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2009
11/03/2009	US7611833 Comprising an altered MAB1, MAB2, MAB3, or OLE1 gene; evaluating a substance as a positive strand RNA antiviral agent
11/03/2009	US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
11/03/2009	US7611719 Enterovirus, vaccines, medicaments and diagnostic kits
11/03/2009	US7611718 Attenuation of cytomegalovirus virulence
11/03/2009	US7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
11/03/2009	US7611706 RG1 antibodies and uses thereof
11/03/2009	US7611670 Quantitative analysis of a biological sample of unknown quantity
11/03/2009	US7611621 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices
11/03/2009	CA2414618C Composite arrays utilizing microspheres with a hybridization chamber
11/03/2009	CA2402693C High throughput screening by measurement of intracellular calcium levels
11/03/2009	CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009	CA2342767C Multihued labels
11/03/2009	CA2340670C An anthraquinone and its derivatives
11/03/2009	CA2252648C Non-invasive enzyme screen for tissue remodelling-associated conditions
11/03/2009	CA2231745C In-vitro transcription processes for screening natural products and other chemical substances
11/03/2009	CA2205379C Yeast-based delivery vehicles
11/03/2009	CA2181548C Zinc finger protein derivatives and methods therefor
11/03/2009	CA2155813C Agents and a method of chromosome preparation using protein phosphatase inhibitors induced premature chromosome condensation
11/03/2009	CA2118243C Methods and compositions for monitoring cellular processing of .beta.-amyloid precursor protein
10/2009
10/29/2009	WO2009132354A2 Method for confirming the presence of an analyte
10/29/2009	WO2009132315A1 Method of sequencing and mapping target nucleic acids
10/29/2009	WO2009132308A2 Methods of identifying agents that promote axonal development
10/29/2009	WO2009132273A2 Microrna biomarkers of tissue injury
10/29/2009	WO2009132271A2 Risk stratification of genetic disease using scoring of amino acid residue conservation in protein families
10/29/2009	WO2009132260A1 Protein engineering of monoacylglycerol lipase (mgll)
10/29/2009	WO2009132257A2 Cytological methods for detecting cancer
10/29/2009	WO2009132244A1 Methods for preparing immunogenic compositions
10/29/2009	WO2009132196A2 Drug discovery methods involving a preclinical, in vitro isolated gastrointestinal epithelial stem cell-like progenitor cell system
10/29/2009	WO2009132126A2 Method for predicting risk of metastasis
10/29/2009	WO2009132124A2 Geometric patterns and lipid bilayers for dna molecule organization and uses thereof
10/29/2009	WO2009132103A2 Microsequencer-whole genome sequencer
10/29/2009	WO2009131964A2 Method of detecting calcifying nanoparticles and susceptibility to calcifying nanoparticle formation
10/29/2009	WO2009131948A2 High-throughput cell-based cftr assay
10/29/2009	WO2009131919A2 Polymerases for incorporating modified nucleotides
10/29/2009	WO2009131887A2 Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancer
10/29/2009	WO2009131805A1 Nucleic acid terminators incorporating a cationic moiety and methods for their use
10/29/2009	WO2009131776A1 High throughput flow through sample preparation using magnetic beads
10/29/2009	WO2009131758A1 A reagent containing a thermostable endonuclease
10/29/2009	WO2009131733A1 Gab2 amplification in melanoma
10/29/2009	WO2009131728A2 Compositions for use in identification of picornaviruses
10/29/2009	WO2009131710A2 Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof
10/29/2009	WO2009131683A2 Method for detecting chikungunya virus
10/29/2009	WO2009131645A2 Methods and apparatus for segregation of particles
10/29/2009	WO2009131366A2 Cdca5 as a diagnosis marker and therapeutic agent for gastric cancer or colorectal cancer
10/29/2009	WO2009131365A2 Cst1, dcc1, ifitm1 or melk as markers for diagnosing stomach cancer
10/29/2009	WO2009131223A1 Method for analysis of dna methylation
10/29/2009	WO2009131203A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus
10/29/2009	WO2009131194A1 Apparatus, kit and method for detection of cholinesterase-inhibiting substance
10/29/2009	WO2009130797A1 Probe set for determining abo blood type
10/29/2009	WO2009130480A1 Analysis of nucleic acids
10/29/2009	WO2009130465A2 Markers
10/29/2009	WO2009130367A1 Method for maintaining intestial bacteria in balance
10/29/2009	WO2009130320A2 Measurement of protein kinase activity in cerebrospinal fluid for diagnosis of neurological and psychiatric disorders
10/29/2009	WO2009130176A1 Antiviral Therapy
10/29/2009	WO2009129693A1 Probes, liquidchip-based products, and methods for detection of egfr gene mutation
10/29/2009	WO2009129619A1 Aptamers for detection and imaging of apoptosis
10/29/2009	WO2009129558A1 Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms
10/29/2009	WO2009111643A3 Microrna markers for recurrence of colorectal cancer
10/29/2009	WO2009111485A3 Infection mediated foam dissolution rate measurement
10/29/2009	WO2009111269A3 Cell-based methods for detecting and/or measuring bmp-12-related protein activity
10/29/2009	WO2009100284A3 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects
10/29/2009	WO2009100159A3 Methods of diagnosing and treating parp-mediated diseases
10/29/2009	WO2009097418A3 Sr-bi as a predictor of elevated high density lipoprotein and cardiovascular disease
10/29/2009	WO2009093856A3 Pcr primer set for detecting mycoplasma in biological medicinal products, and a kit for detecting mycoplasma comprising the same
10/29/2009	WO2009091148A3 Primer, probe, dna chip containing the same and method for detecting human papillomavirus and detection kit thereof
10/29/2009	WO2009083780A8 Breast cancer expression profiling
10/29/2009	WO2009080017A3 Marker sequence for neurodegenerative diseases and the use thereof
10/29/2009	WO2009077173A3 Dna-encoded chemical libraries
10/29/2009	WO2009071920A3 Methods for identifying epigenetically silenced genes and novel tumour suppressor genes
10/29/2009	WO2009055530A3 Dental composition for detecting bacteria, kit of parts and use thereof
10/29/2009	WO2009049257A9 Predictive models and methods for diagnosing and assessing coronary artery disease
10/29/2009	WO2009046426A3 Compounds and methods for improving cellular uptake of oligomeric compounds
10/29/2009	WO2009039586A3 Biomarkers for parkinson's disease
10/29/2009	WO2008118877A8 Method of diagnosing, classifying and treating endometrial cancer and precancer
10/29/2009	US20090271895 Plants having improved growth characteristics and method for making the same
10/29/2009	US20090271894 transgenic plant with mutant UPB1 (UPBEAT1) gene for increased cellulosic biomass per acre; fermentation to produce bioethanol; agronomics
10/29/2009	US20090271890 Method for obtaining a plant with a lasting resistance to a pathogen
10/29/2009	US20090271123 Ordering genes by analysis of expression kinetics
10/29/2009	US20090270704 Patches, systems, and methods for non-invasive glucose measurement
10/29/2009	US20090270602 Peptide nucleic acids with donor and acceptor moieties for detecting or identifying the presence, absence or quantity of a target sequence of a target molecule such as via fluorescence resonance energy transfer
10/29/2009	US20090270597 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
10/29/2009	US20090270591 Novel surface antigen
10/29/2009	US20090270512 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal
10/29/2009	US20090270506 Crystalline structure of oxidosqualene synthase
10/29/2009	US20090270504 Treatment of Huntington's Disease With EPA
10/29/2009	US20090270483 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
10/29/2009	US20090270482 Analysis of methylated nucleic acid
10/29/2009	US20090270480 Markers and Methods for Assessing and Treating Psoriasis and Related Disorders
10/29/2009	US20090270479 Genetic and Epigenetic Alterations In the Diagnosis and Treatment of Cancer
10/29/2009	US20090270408 Amide derivatives as positive allosteric modulators and methods of use thereof
10/29/2009	US20090270332 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
10/29/2009	US20090270327 Lepidopteran-Active Bacillus Thuringiensis Delta-Endotoxin Compositions and Methods of Use
10/29/2009	US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009	US20090270271 3' Biased Detection of Nucleic Acids
10/29/2009	US20090270270 Method for detecting intragenic large rearrangements
10/29/2009	US20090270268 Methods for Obtaining Immortalized Antibody Secreting Cells
10/29/2009	US20090270267 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
10/29/2009	US20090270265 Molecular Characteristics of Non-Small Cell Lung Cancer
10/29/2009	US20090269837 System for assessing the efficacy of stored red blood cells using microvascular networks
10/29/2009	US20090269836 Apparatus and Method for Analysing a Biological Sample in Response to Microwave Radiation

1 ... 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 ... 3003